Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care – Protocol for a health economic evaluation alongside a randomized controlled trial
Background Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-...
Saved in:
| Published in: | BMC geriatrics Vol. 24; no. 1; pp. 231 - 14 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
06.03.2024
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1471-2318, 1471-2318 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery.
Methods
The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care.
Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses.
Discussion
The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population.
Trial registration
PRAEP-GO RCT: NCT04418271; economic evaluation: OSF (
https://osf.io/ecm74
). |
|---|---|
| AbstractList | Background Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery. Methods The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged [greater than or equal to]70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses. Discussion The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population. Trial registration PRAEP-GO RCT: NCT04418271; economic evaluation: OSF ( Keywords: Health care economics, Health care evaluation mechanisms, Cost-effectiveness analysis, Trial-based health economic evaluation, Prehabilitation, Preoperative exercise, Frailty Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery. The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged [greater than or equal to]70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population. Abstract Background Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery. Methods The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses. Discussion The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population. Trial registration PRAEP-GO RCT: NCT04418271; economic evaluation: OSF ( https://osf.io/ecm74 ). Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery.BACKGROUNDPrehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery.The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses.METHODSThe planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses.The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population.DISCUSSIONThe health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population.PRAEP-GO RCT: NCT04418271; economic evaluation: OSF ( https://osf.io/ecm74 ).TRIAL REGISTRATIONPRAEP-GO RCT: NCT04418271; economic evaluation: OSF ( https://osf.io/ecm74 ). Background Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery. Methods The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses. Discussion The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population. Trial registration PRAEP-GO RCT: NCT04418271; economic evaluation: OSF ( https://osf.io/ecm74 ). BackgroundPrehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery.MethodsThe planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care.Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses.DiscussionThe health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population.Trial registrationPRAEP-GO RCT: NCT04418271; economic evaluation: OSF (https://osf.io/ecm74). Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability of disability. The planned economic evaluation is performed alongside a large German multi-centre pragmatic, two-arm parallel-group, randomized controlled trial on prehabilitation for frail elderly patients before elective surgery compared to standard care (PRAEP-GO RCT). The aim is to determine the cost-effectiveness and cost-utility of prehabilitation for frail elderly before an elective surgery. The planned health economic evaluation comprises cost-effectiveness, and cost-utility analyses. Analyses are conducted in the German context from different perspectives including the payer perspective, i.e. the statutory health insurance, the societal perspective and the health care provider perspective. Data on outcomes and costs, are collected alongside the ongoing PRAEP-GO RCT. The trial population includes frail or pre-frail patients aged ≥70 years with planned elective surgery. The intervention consists of frailty screening (Fried phenotype), a shared decision-making conference determining modality (physiotherapy and unsupervised physical exercises, nutrition counselling, etc.) and setting (inpatient, day care, outpatient etc.) of a 3-week individual multimodal prehabilitation prior to surgery. The control group receives standard preoperative care. Costs include the intervention costs, the costs of the index hospital stay for surgery, and health care resources consumed during a 12-month follow-up. Clinical effectiveness outcomes included in the economic evaluation are the level of care dependency, the degree of disability as measured by the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0), quality-adjusted life years (QALY) derived from the EQ-5D-5L and the German utility set, and complications occurring during the index hospital stay. Each adopted perspective considers different types of costs and outcomes as outlined in the protocol. All analyses will feature Intention-To-Treat analysis. To explore methodological and parametric uncertainties, we will conduct probabilistic and deterministic sensitivity analyses. Subgroup analyses will be performed as secondary analyses. The health economic evaluation will provide insights into the cost-effectiveness of prehabilitation in older frail populations, informing decision-making processes and contributing to the evidence base in this field. Potential limitation includes a highly heterogeneous trial population. PRAEP-GO RCT: NCT04418271; economic evaluation: OSF ( https://osf.io/ecm74 ). |
| ArticleNumber | 231 |
| Audience | Academic |
| Author | Quentin, Wilm Busse, Reinhard Eckhardt, Helene Rombey, Tanja Silzle, Julia |
| Author_xml | – sequence: 1 givenname: Helene orcidid: 0000-0002-3921-428X surname: Eckhardt fullname: Eckhardt, Helene email: helene.eckhardt@tu-berlin.de organization: Department of Health Care Management, Institute of Technology and Management, Technische Universität Berlin – sequence: 2 givenname: Wilm orcidid: 0000-0002-1705-6524 surname: Quentin fullname: Quentin, Wilm organization: Department of Health Care Management, Institute of Technology and Management, Technische Universität Berlin, Planetary & Public Health, University of Bayreuth – sequence: 3 givenname: Julia orcidid: 0000-0002-5707-0267 surname: Silzle fullname: Silzle, Julia organization: Department of Health Care Management, Institute of Technology and Management, Technische Universität Berlin – sequence: 4 givenname: Reinhard orcidid: 0000-0003-4961-9130 surname: Busse fullname: Busse, Reinhard organization: Department of Health Care Management, Institute of Technology and Management, Technische Universität Berlin – sequence: 5 givenname: Tanja orcidid: 0000-0001-5777-9738 surname: Rombey fullname: Rombey, Tanja organization: Department of Health Care Management, Institute of Technology and Management, Technische Universität Berlin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38448804$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1TAQhiNURC_wAiyQJTZlkWInTuKs0FFVSqVKrRCsLccZn-PKJy62c6R2xTvwdGx5EiZN6U2oyiL2zDe_PeN_N9sa_ABZ9pbRA8ZE_TGyQjRNTgueUy7KMq9eZDuMNywvSia2Hqy3s90YLyhljSjqV9l2KTgXgvKd7PehjykHY0Anu4EBYiTekMsAK9VZZ5NK1g9TCFwPwV0RE5R1xIeJyefNJUIwpIghi4nkEZ71SBzDEsIV2T__ujg6z4_PPpANhDhGMsZROaJVAPLn5y9yHnzy2jtiUEGRFSiXVgS0H_zaagIb5cb5Lsr5YRltD4gFNfSYv4aeIJmCdw6XKVjlXmcvjXIR3tz-97Lvn4--HX7JT8-OTw4Xp7muqUh5o4qyK1VfdkXb16bujaItY7QvdaF1zVmjK9X3hnW04UUlMMiNhpJ1XLUlo-VedjLr9l5dSJzAWoUr6ZWVNwEfllKFZLUDCaKpG95q2oqKM3yB2nSNUXXHNNOlFqj1ada6HLs19BqHGpR7JPo4M9iVXPqNZHjnmhUtKuzfKgT_Y4SY5NpGDc6pAfwYZdHygomq4RWi75-gF34MA84KqaoWFW0rcU8tFXZgB-PxYD2JykUjqpoWbT1pHfyHwq8HfD20rbEYf1Tw7mGndy3-cyYCxQzo4GMMYO4QRuVkfznbX6L95Y395aQqnhTpWwenyajPl5ZzacRzBvTs_TSeqfoLLBcdyQ |
| CitedBy_id | crossref_primary_10_1007_s40140_024_00659_4 crossref_primary_10_1109_JSEN_2024_3510626 |
| Cites_doi | 10.1001/jamanetworkopen.2023.8050 10.1007/s40273-014-0193-3 10.1186/s13019-021-01541-8 10.1007/s10198-009-0173-2 10.1186/s13063-022-06401-x 10.1136/bmj.c869 10.1016/S0140-6736(00)02039-0 10.1186/s12874-015-0022-1 10.1055/s-0028-1102930 10.1080/01621459.1962.10480664 10.1097/SLA.0000000000002132 10.1007/s40273-018-0615-8 10.1001/jama.2022.21506 10.1097/01.sla.0000133083.54934.ae 10.1007/s12603-021-1609-3 10.1007/s10198-015-0731-8 10.1016/j.jbi.2008.08.010 10.1016/j.jval.2021.10.008 10.3390/cancers15061881 10.1007/s00268-020-05658-0 10.1245/s10434-021-11321-2 10.1016/j.jval.2015.02.001 10.1097/SLA.0b013e3181b13ca2 10.1093/med/9780199685028.001.0001 10.1093/oso/9780192631770.003.0008 10.1186/s12916-023-02977-6 10.1007/s11136-014-0837-y 10.1093/eurheartj/ehac270 10.1007/978-3-319-55718-2 10.1123/japa.2017-0188 10.1016/j.jclinepi.2021.01.008 10.1093/ptj/pzac169 10.1002/icd.2407 10.1007/978-1-4899-4541-9 10.1016/j.ejso.2023.01.024 10.21203/rs.3.rs-3125799/v1 10.1002/hec.4730030505 10.1186/s12891-016-1369-0 10.1080/00273171.2011.568786 10.1097/SLA.0b013e318296c732 10.3390/cancers15061671 10.1001/jamasurg.2019.5474 10.1007/s11606-012-2077-6 10.1016/j.bja.2021.11.018 10.1136/bmj.j4891 10.1186/s12955-021-01719-7 10.1016/j.jss.2021.05.018 10.1007/s10195-015-0337-z 10.1177/0962280211419832 10.31616/asj.2022.0262 10.1002/sim.4067 10.1186/s12913-021-06513-1 10.1177/0272989X07302132 10.1016/j.ijsu.2020.11.004 10.1111/aas.13239 10.1016/j.jamda.2016.09.010 10.1007/s10549-022-06759-1 10.1002/hec.843 10.1093/gerona/56.3.M146 10.1111/j.1524-4733.2008.00358.x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12877-024-04833-5 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Economics Physical Therapy |
| EISSN | 1471-2318 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_e876749c0985414886fb7fa6b1c1c3c8 PMC10916129 A785602965 38448804 10_1186_s12877_024_04833_5 |
| Genre | Clinical Trial Protocol Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Germany |
| GeographicLocations_xml | – name: Germany |
| GrantInformation_xml | – fundername: Innovation Fund coordinated by the Innovation Committee of the Federal Joint Committee in Germany (Innovationsausschuss beim Gemeinsamen Bundesausschuss (G-BA)) grantid: 01NVF18024; 01NVF18024; 01NVF18024; 01NVF18024; 01NVF18024 – fundername: Technische Universität Berlin (3136) – fundername: Innovation Fund coordinated by the Innovation Committee of the Federal Joint Committee in Germany (Innovationsausschuss beim Gemeinsamen Bundesausschuss (G-BA)) grantid: 01NVF18024 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACHQT ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7XB 8FK AEUYN AZQEC COVID DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c608t-7a23b3ad3b29d6f6dfa09110d3c2cc6417c5addf1b0742582cc4fce31b4a93103 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001180601900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2318 |
| IngestDate | Fri Oct 03 12:44:42 EDT 2025 Tue Nov 04 02:05:47 EST 2025 Sat Nov 01 15:08:50 EDT 2025 Tue Oct 07 05:18:40 EDT 2025 Sat Nov 29 14:11:57 EST 2025 Sat Nov 29 10:41:52 EST 2025 Thu Aug 28 04:41:03 EDT 2025 Tue Nov 18 21:23:57 EST 2025 Sat Nov 29 01:39:04 EST 2025 Sat Sep 06 07:29:43 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Cost-effectiveness analysis Trial-based health economic evaluation Prehabilitation Preoperative exercise Frailty Health care evaluation mechanisms Health care economics |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c608t-7a23b3ad3b29d6f6dfa09110d3c2cc6417c5addf1b0742582cc4fce31b4a93103 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23 |
| ORCID | 0000-0002-1705-6524 0000-0003-4961-9130 0000-0002-5707-0267 0000-0002-3921-428X 0000-0001-5777-9738 |
| OpenAccessLink | https://www.proquest.com/docview/2956850958?pq-origsite=%requestingapplication% |
| PMID | 38448804 |
| PQID | 2956850958 |
| PQPubID | 44817 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e876749c0985414886fb7fa6b1c1c3c8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10916129 proquest_miscellaneous_2942185745 proquest_journals_2956850958 gale_infotracmisc_A785602965 gale_infotracacademiconefile_A785602965 pubmed_primary_38448804 crossref_primary_10_1186_s12877_024_04833_5 crossref_citationtrail_10_1186_s12877_024_04833_5 springer_journals_10_1186_s12877_024_04833_5 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-03-06 |
| PublicationDateYYYYMMDD | 2024-03-06 |
| PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC geriatrics |
| PublicationTitleAbbrev | BMC Geriatr |
| PublicationTitleAlternate | BMC Geriatr |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | G Elwyn (4833_CR32) 2017; 359 4833_CR60 4833_CR27 D Dindo (4833_CR39) 2004; 240 R Faria (4833_CR68) 2014; 32 BA van Hout (4833_CR78) 1994; 3 K Slankamenac (4833_CR42) 2013; 258 4833_CR24 4833_CR22 4833_CR66 4833_CR21 PC Austin (4833_CR61) 2011; 46 D Husereau (4833_CR25) 2022; 25 P-A Clavien (4833_CR40) 2017; 265 P Hayati Rezvan (4833_CR67) 2015; 15 4833_CR28 JF Shaw (4833_CR6) 2022; 29 DJ Johnson (4833_CR63) 2015; 16 SD Ramsey (4833_CR23) 2015; 18 4833_CR52 JA Lee (4833_CR5) 2021; 16 4833_CR51 R Chan (4833_CR3) 2022; 128 GR Barton (4833_CR79) 2008; 11 J-O Bock (4833_CR49) 2015; 77 X Yu (4833_CR2) 2021; 85 KJ Lee (4833_CR69) 2021; 134 4833_CR16 S Braun (4833_CR50) 2009; 71 4833_CR58 4833_CR13 CL Simons (4833_CR65) 2015; 24 4833_CR11 4833_CR53 CJ Molenaar (4833_CR9) 2023; 5 T Mantopoulos (4833_CR62) 2016; 17 4833_CR18 F Carli (4833_CR15) 2020; 155 D Moher (4833_CR56) 2010; 340 G Elwyn (4833_CR31) 2012; 27 AR Willan (4833_CR70) 2004; 13 M Ruiz (4833_CR1) 2021; 267 DA Milder (4833_CR12) 2018; 62 4833_CR41 A Zellner (4833_CR72) 1962; 57 MJ Lambrechts (4833_CR4) 2023; 17 S Halvorsen (4833_CR59) 2022; 43 4833_CR83 MZ Chen (4833_CR26) 2021; 25 G Baio (4833_CR74) 2015; 24 4833_CR81 K Toohey (4833_CR17) 2023; 197 4833_CR80 A Punnoose (4833_CR10) 2023; 6 4833_CR47 4833_CR46 4833_CR45 4833_CR44 M Baimas-George (4833_CR14) 2020; 44 PA Clavien (4833_CR38) 2009; 250 O Marten (4833_CR43) 2021; 19 PA Harris (4833_CR54) 2009; 42 A Manca (4833_CR71) 2007; 27 MJ Holmberg (4833_CR57) 2022; 328 4833_CR30 Jönsson B Ten (4833_CR33) 2009; 10 4833_CR73 SF Assmann (4833_CR55) 2000; 355 L Fernandes (4833_CR82) 2017; 18 H Seidl (4833_CR48) 2015; 77 4833_CR37 IR White (4833_CR64) 2011; 30 4833_CR36 4833_CR35 T Rombey (4833_CR19) 2023; 21 4833_CR34 S Vermeiren (4833_CR7) 2016; 17 4833_CR77 4833_CR76 4833_CR75 SJ Schaller (4833_CR20) 2022; 23 LP Fried (4833_CR29) 2001; 56 P Lopez (4833_CR8) 2018; 26 |
| References_xml | – volume: 6 start-page: e238050 issue: 4 year: 2023 ident: 4833_CR10 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2023.8050 – ident: 4833_CR34 – volume: 77 start-page: 46 issue: 1 year: 2015 ident: 4833_CR48 publication-title: Gesundheitswesen – ident: 4833_CR30 – volume: 32 start-page: 1157 issue: 12 year: 2014 ident: 4833_CR68 publication-title: Pharmacoeconomics doi: 10.1007/s40273-014-0193-3 – volume: 16 start-page: 184 issue: 1 year: 2021 ident: 4833_CR5 publication-title: J Cardiothorac Surg doi: 10.1186/s13019-021-01541-8 – volume: 10 start-page: 357 issue: 4 year: 2009 ident: 4833_CR33 publication-title: Eur J Health Econ doi: 10.1007/s10198-009-0173-2 – ident: 4833_CR53 – volume: 23 start-page: 468 issue: 1 year: 2022 ident: 4833_CR20 publication-title: Trials doi: 10.1186/s13063-022-06401-x – ident: 4833_CR44 – volume: 340 start-page: c869 year: 2010 ident: 4833_CR56 publication-title: BMJ doi: 10.1136/bmj.c869 – volume: 355 start-page: 1064 issue: 9209 year: 2000 ident: 4833_CR55 publication-title: Lancet doi: 10.1016/S0140-6736(00)02039-0 – volume: 15 start-page: 30 year: 2015 ident: 4833_CR67 publication-title: BMC Med Res Methodol doi: 10.1186/s12874-015-0022-1 – volume: 71 start-page: 19 issue: 1 year: 2009 ident: 4833_CR50 publication-title: Gesundheitswesen doi: 10.1055/s-0028-1102930 – volume: 57 start-page: 348 issue: 298 year: 1962 ident: 4833_CR72 publication-title: J Am Stat Assoc doi: 10.1080/01621459.1962.10480664 – ident: 4833_CR21 – volume: 265 start-page: 1045 issue: 6 year: 2017 ident: 4833_CR40 publication-title: Ann Surg doi: 10.1097/SLA.0000000000002132 – ident: 4833_CR35 doi: 10.1007/s40273-018-0615-8 – volume: 328 start-page: 2155 issue: 21 year: 2022 ident: 4833_CR57 publication-title: JAMA doi: 10.1001/jama.2022.21506 – volume: 240 start-page: 205 issue: 2 year: 2004 ident: 4833_CR39 publication-title: Ann Surg doi: 10.1097/01.sla.0000133083.54934.ae – ident: 4833_CR60 – volume: 25 start-page: 637 issue: 5 year: 2021 ident: 4833_CR26 publication-title: J Nutr Health Aging doi: 10.1007/s12603-021-1609-3 – volume: 17 start-page: 927 issue: 8 year: 2016 ident: 4833_CR62 publication-title: Eur J Health Econ doi: 10.1007/s10198-015-0731-8 – volume: 42 start-page: 377 issue: 2 year: 2009 ident: 4833_CR54 publication-title: J Biomed Inform doi: 10.1016/j.jbi.2008.08.010 – volume: 25 start-page: 10 issue: 1 year: 2022 ident: 4833_CR25 publication-title: Value Health doi: 10.1016/j.jval.2021.10.008 – ident: 4833_CR37 – ident: 4833_CR16 doi: 10.3390/cancers15061881 – volume: 44 start-page: 3668 issue: 11 year: 2020 ident: 4833_CR14 publication-title: World J Surg doi: 10.1007/s00268-020-05658-0 – volume: 29 start-page: 4690 issue: 8 year: 2022 ident: 4833_CR6 publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-11321-2 – volume: 18 start-page: 161 issue: 2 year: 2015 ident: 4833_CR23 publication-title: Value Health doi: 10.1016/j.jval.2015.02.001 – ident: 4833_CR47 – volume: 250 start-page: 187 issue: 2 year: 2009 ident: 4833_CR38 publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181b13ca2 – ident: 4833_CR24 doi: 10.1093/med/9780199685028.001.0001 – ident: 4833_CR76 doi: 10.1093/oso/9780192631770.003.0008 – volume: 21 start-page: 265 issue: 1 year: 2023 ident: 4833_CR19 publication-title: BMC Med doi: 10.1186/s12916-023-02977-6 – volume: 24 start-page: 805 issue: 4 year: 2015 ident: 4833_CR65 publication-title: Qual Life Res doi: 10.1007/s11136-014-0837-y – ident: 4833_CR81 – volume: 43 start-page: 3826 issue: 39 year: 2022 ident: 4833_CR59 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehac270 – ident: 4833_CR75 doi: 10.1007/978-3-319-55718-2 – ident: 4833_CR36 – volume: 26 start-page: 407 issue: 3 year: 2018 ident: 4833_CR8 publication-title: J Aging Phys Act doi: 10.1123/japa.2017-0188 – volume: 134 start-page: 79 year: 2021 ident: 4833_CR69 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2021.01.008 – ident: 4833_CR18 doi: 10.1093/ptj/pzac169 – ident: 4833_CR66 doi: 10.1002/icd.2407 – ident: 4833_CR73 doi: 10.1007/978-1-4899-4541-9 – ident: 4833_CR51 – ident: 4833_CR11 doi: 10.1016/j.ejso.2023.01.024 – ident: 4833_CR22 doi: 10.21203/rs.3.rs-3125799/v1 – volume: 3 start-page: 309 issue: 5 year: 1994 ident: 4833_CR78 publication-title: Health Econ doi: 10.1002/hec.4730030505 – ident: 4833_CR46 – volume: 18 start-page: 5 issue: 1 year: 2017 ident: 4833_CR82 publication-title: BMC Musculoskelet Disord doi: 10.1186/s12891-016-1369-0 – volume: 46 start-page: 399 issue: 3 year: 2011 ident: 4833_CR61 publication-title: Multivariate Behav Res doi: 10.1080/00273171.2011.568786 – volume: 258 start-page: 1 issue: 1 year: 2013 ident: 4833_CR42 publication-title: Ann Surg doi: 10.1097/SLA.0b013e318296c732 – ident: 4833_CR13 doi: 10.3390/cancers15061671 – volume: 155 start-page: 233 issue: 3 year: 2020 ident: 4833_CR15 publication-title: JAMA Surg doi: 10.1001/jamasurg.2019.5474 – ident: 4833_CR27 – volume: 27 start-page: 1361 issue: 10 year: 2012 ident: 4833_CR31 publication-title: J Gen Intern Med doi: 10.1007/s11606-012-2077-6 – volume: 128 start-page: 258 issue: 2 year: 2022 ident: 4833_CR3 publication-title: Br J Anaesth doi: 10.1016/j.bja.2021.11.018 – volume: 359 start-page: j4891 year: 2017 ident: 4833_CR32 publication-title: BMJ doi: 10.1136/bmj.j4891 – ident: 4833_CR80 – volume: 19 start-page: 76 issue: 1 year: 2021 ident: 4833_CR43 publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-021-01719-7 – ident: 4833_CR83 – volume: 267 start-page: 495 year: 2021 ident: 4833_CR1 publication-title: J Surg Res doi: 10.1016/j.jss.2021.05.018 – ident: 4833_CR52 – volume: 5 start-page: CD013259 year: 2023 ident: 4833_CR9 publication-title: Cochrane Database Syst Rev – volume: 16 start-page: 209 issue: 3 year: 2015 ident: 4833_CR63 publication-title: J Orthop Traumatol doi: 10.1007/s10195-015-0337-z – volume: 24 start-page: 615 issue: 6 year: 2015 ident: 4833_CR74 publication-title: Stat Methods Med Res doi: 10.1177/0962280211419832 – volume: 17 start-page: 313 issue: 2 year: 2023 ident: 4833_CR4 publication-title: Asian Spine J doi: 10.31616/asj.2022.0262 – volume: 30 start-page: 377 issue: 4 year: 2011 ident: 4833_CR64 publication-title: Statist Med doi: 10.1002/sim.4067 – ident: 4833_CR58 doi: 10.1186/s12913-021-06513-1 – volume: 27 start-page: 471 issue: 4 year: 2007 ident: 4833_CR71 publication-title: Med Decis Making doi: 10.1177/0272989X07302132 – ident: 4833_CR77 – volume: 85 start-page: 30 year: 2021 ident: 4833_CR2 publication-title: Int J Surg doi: 10.1016/j.ijsu.2020.11.004 – volume: 62 start-page: 1356 issue: 10 year: 2018 ident: 4833_CR12 publication-title: Acta Anaesthesiol Scand doi: 10.1111/aas.13239 – volume: 17 start-page: 1163.e1 issue: 12 year: 2016 ident: 4833_CR7 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2016.09.010 – volume: 197 start-page: 1 issue: 1 year: 2023 ident: 4833_CR17 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-022-06759-1 – ident: 4833_CR45 – volume: 13 start-page: 461 issue: 5 year: 2004 ident: 4833_CR70 publication-title: Health Econ doi: 10.1002/hec.843 – volume: 56 start-page: M146 issue: 3 year: 2001 ident: 4833_CR29 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – ident: 4833_CR41 – volume: 11 start-page: 886 issue: 5 year: 2008 ident: 4833_CR79 publication-title: Value Health doi: 10.1111/j.1524-4733.2008.00358.x – ident: 4833_CR28 – volume: 77 start-page: 53 issue: 1 year: 2015 ident: 4833_CR49 publication-title: Gesundheitswesen |
| SSID | ssj0017826 |
| Score | 2.3661199 |
| Snippet | Background
Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease... Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease probability... Background Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease... BackgroundPrehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and decrease... Abstract Background Prehabilitation aims to improve patients' functional capacity before surgery to reduce perioperative complications, promote recovery and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 231 |
| SubjectTerms | Aged Aging Clinical trials Comparative analysis Cost analysis Cost benefit analysis Cost-effectiveness analysis Decision making Economics Elective surgery Evaluation Exercise Exercise therapy Frail Elderly Frailty Genotype & phenotype Geriatrics/Gerontology Health care Health care economics Health care evaluation mechanisms Health care industry Health care policy Health insurance Heart surgery Humans Inpatients Intervention Medical care, Cost of Medicine Medicine & Public Health Multicenter Studies as Topic Older people Orthopedics Outpatients Patients Phenotypes Physical therapy Prehabilitation Preoperative Exercise Randomized Controlled Trials as Topic Rehabilitation Sensitivity analysis Shared decision making Study Protocol Surgery Teams Trial-based health economic evaluation |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJuFgoyEBAis5unHsVQtHKCsEKDeLMexy0qrpEqySHDiP_DruPJLmHG826YIuHDb-JHY3s8zY3nmG0IeqSwRBhQjAwBlrJDKw5ZKFPPSVYlPDfeBUujja3F4KI-O1PxMqi_0CRvpgceF23ES6WaUTZTEjNVScl8Jb3iV2tTmNoT5JkKtD1Px_gD0Hl-HyEi-04MUFoKBPmJIoZ6zcqKGAlv_7zL5jFI67zB57tY0KKODq-RKtCLp7jj6a-SCa66TS2_iPfkN8mOv7Qc2-mpEcUZbT0-6CS83FjnM0r38Qn1nFkvadtiGjQ-RcrWHogVUDC0NOXPgfbQfg6npk_m73f05e_n2KUX3jlVPV_0KBob-ZPTnt-903rVDC1ijYBtTQ8eoS-piNDQ95RqnZtk2x5g7FJqB_qyh_quraXSlX8LPkGDkJvlwsP9-7xWLSRyY5YkcmDBZXuWmzqtM1dzz2hswUdKkzm1mLS9SYUuQsT6t8JReSigsvHV5WhVGYRK0W2SraRt3h9CqzBT6GypVwSFW2CqpCuWsE4l0XqpyRtL1f6ptXElMtLHU4aQjuR5xoAEHOuBAQ59nmz4nI7_HX1u_QKhsWiI3dygAxOqIWP0vxM7IYwSaRgkCw7MmBkLAJJGLS-8KCWZopjh8bnvSEna-nVavoaqj5Ol1hvGfYAWW8J2Hm2rsid50jWtX2KbIkAOsgFfcHpG9mVIuC5TpxYzICeYnc57WNItPgZccOWbBYFYz8ny9PU7H9edFvfs_FvUeuZyF7Y25SrbJ1tCt3H1y0X4eFn33IAiHX9XUaeg priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagIMSF92OhICMhAaIWecc-LlULByirAlVvluPYZaVVUuWBBCf-A7-OK7-EGcfZkvKQ4LZrjxM7npflmW8IeSiiIFdgGBkwUMQSLiyIVCCY5aYIbKgy6yCFDl7le3v88FAsfFJYO0a7j1eSTlM7sebZsxY0aZ4zsCkMYdBjlp4l58DccSzYsP_2YH13ADYvG9NjfjtuYoIcUv-v-vgng3Q6WPLUjakzRLuX_28JV8gl73jS-cApV8kZU10jF177q_Xr5Nt23XZsCO_wGpDWlh43EyhvbDJY2Hv1idpGLVe0bpCGDX88SmsLTUvo6GrqyuzA82g75F_Tx4v9-c6CvXjzhGJESN_Svu1hYhiCRr9_-UoXTd3VwJ4U3Gmq6JCoSY1PoKYn8ORUrerqCMuNAhmY3BL6P5uS-uj7Ffx0NUlukPe7O--2XzJf94HpLOAdy1UUF7Eq4yISZWaz0irwasKgjHWkdZaEuU5BLduwwIN9yqExsdrEYZEogXXTbpKNqq7MbUKLNBIYoihEAefeXBdBkQijTR5wY7lIZyQcWUFq_yWxNsdKusMRz-SwZxL2TLo9kzDm6XrM8QAJ8lfq58hha0qE83YNdXMkvXaQhiOmktDAzViWnfPMFrlVWRHqUMeaz8gj5E-JSgemp5XPnYBFInyXnOccPNdIZPC6zQklKAs97R45XHpl1coIU0ZBklJ4z4N1N47EALzK1D3SJBHChiXwiFuDQKyXFPMEzUAyI3wiKpM1T3uq5QcHZY6wtOBjixnZGiXmZF5__qh3_o38LrkYOaHDQiabZKNrenOPnNcfu2Xb3Hfa4wep9W6h priority: 102 providerName: Springer Nature |
| Title | Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care – Protocol for a health economic evaluation alongside a randomized controlled trial |
| URI | https://link.springer.com/article/10.1186/s12877-024-04833-5 https://www.ncbi.nlm.nih.gov/pubmed/38448804 https://www.proquest.com/docview/2956850958 https://www.proquest.com/docview/2942185745 https://pubmed.ncbi.nlm.nih.gov/PMC10916129 https://doaj.org/article/e876749c0985414886fb7fa6b1c1c3c8 |
| Volume | 24 |
| WOSCitedRecordID | wos001180601900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-2318 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017826 issn: 1471-2318 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgQ8ALg_JVGJWRkAANa_lqYj-hbuoAiZWojKk8RYljj0pVUpIWCZ74H_jreOUv4c5xWzLEXnipavuc-tLznT_ufkfIE-E5UQqGkYEAeSzgQsOUcgTTXGWOdtNQG0ih07fRaMQnExHbA7faulWudKJR1Hkp8Yx838O4NrBuff5y_plh1ii8XbUpNC6TbUybjXIeTdYbLhesX7gKlOHhfg26OIoYWCWGQOo-67eMkcHs_1sz_2GazrtNnrs7NSbpaOd_mblJbtjFKB000nOLXFJFh1xbxSrXHXL12F69d8hObP9RetIAEdwmPw_LesEajxCrNGmp6bxqoX9jlcJc4LOvVFfpdEbLCmlYU7DArjVUTaFhUVKTmQeeR-smZJs-i8eDYcxevXtO0YlkWdNlvYSBoNca_fX9B42rclGCRFNYgdOUNrGdVFk-6AbRnKazsjjDDKVABlY6h_ZvKqfWYX8GX00akzvkw9Hw5PA1s6kimAwdvmBR6vmZn-Z-5ok81GGuU1gIuU7uS0_KMHAj2QdNrt0MzwL6HCoDLZXvZkEqMNXaXbJVlIW6T2jW9wR6NQqRwVY5kpmTBUJJFTlcaS76XeKuZCaR9k1iOo9ZYvZTPEwaOUtAzhIjZwn02Vv3mTcoIhdSH6AorikRAdxUlNVZYhVKojjCMAnpCI6Z3DkPdRbpNMxc6Upf8i55ioKcoJ6C4cnUhlsAk4j4lQwiDotdT4Twc7stStAvst28kuHE6rc62QhwlzxeN2NP9NkrVLlEmsBDpLEAHnGvmTlrlnweoOUIuoS35lSL53ZLMf1k0M8RyRaW5aJLXqym32Zc_36pDy5m4yG57hnFgLlOdsnWolqqR-SK_LKY1lXPqBXzyXtk-2A4isc9c3oDpfjNcfwRSuP3p78BE8SI6A |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKQZQLhfAKFDASCBBY3Vd27QNCobS0ahqiKqDczK7XLpGi3bCbgMqJ_8D_4P9w5Zcws4-ELaK3Hrgl9thrO_PwZGe-IeShcKwgBMPIgIEc5nFhQKQswQzXkWXs0DcFpND7XtDv89FIDFbIjzoXBsMqa51YKOo4Vfgf-aaDeW1g3Tr85fQTw6pR-Ha1LqFRssW-Pv4CLlv-Yu81_L6PHGdne7i1y6qqAkz5Fp-xIHTcyA1jN3JE7Bs_NiHYTNuKXeUo5Xt2oDog9MaO0G3scGj0jNKuHXmhwKpcMO85ch70eIDOXjBaOHg2WFu_Tszh_mYOuj8IGFhBhsDtLus0jF9RI-BvS_CHKTwZpnniXW1hAnfW_7fDu0IuV5dt2i2l4ypZ0UmLrNW52HmLXDyoQgtaZH1QcSwdlkAL18jPrTSfsTLipTIKNDV0mjXQzbFJY63zyTE1WTie0DRDGlZ-qYBrc2gaQ8cspUXlIZiP5mVKOn0yOOxuD9ibt08pBsnMczrP57AQjMqjv759p4MsnaUgsRQ8DBrSMneV6mofdInYTsNJmhxhBVYgg1tIDP1fdUyrhIQJfCzKtFwn787k3G-Q1SRN9C1Co44jMGpTiMgDK6kiK_KEVjqwuDZcdNrErnlUquoksVzJRBb-IvdlydcS-FoWfC1hzLPFmGmJknIq9Stk_QUlIpwXDWl2JCuFKTVHmCmhLMGxUj3nvokCE_qRrWzlKt4mj1FwJOphWJ4Kq3QS2CQimsluwOEy7wgfHrfRoAT9qZrdtczISn_ncikwbfJg0Y0jMSYx0ekcaTwHkdQ8mOJmKamLLbncQ8votQlvyHBjz82eZPyxQHdHpF5wO0SbPK_Ffbmufx_q7dO3cZ-s7Q4PerK319-_Qy45hVLCui4bZHWWzfVdckF9no3z7F6h0ij5cNZq4DfY9OCD |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagoIoX7mOhgJGQAIHV3LEfl9IFRFlWHFXfrNixy0pRskqySPDEf-DX8covYcbJbptySIi3XXuc2PFclme-IeS-CLw0A8PIgIECFnFhQaQ8wSw3yrN-llgHKbS_l06n_OBAzI5l8bto99WVZJfTgChNZbu9yG0n4jzZbkCrpikD-8IQEj1k8WlyJsJAejyvv9tf3yOA_UtWqTK_HTcwRw61_1fdfMw4nQycPHF76ozS5ML_L-ciOd87pHTccdAlcsqUl8nm6_7K_Qr5vlM1LevCPnrNSCtLF_UA4hubDBb8Lj5TW2fzglY10rDuT4_e2kDTHDrairryO_A82nR52fTh7O14d8aev3lEMVJk2dBls4SJYWga_fH1G53VVVsB21Jws2lGuwROavrEanoEW06zoioPsQwpkIEpzqH_i8lpH5VfwE9Xq-Qq-TDZfb_zgvX1IJhOPN6yNAtCFWZ5qAKRJzbJbQbeju_loQ60TiI_1TGoa-srPPDHHBojq03oqygTWE_tGtkoq9LcIFTFgcDQRSEUnIdTrTwVCaNN6nFjuYhHxF-xhdT9l8SaHYV0hyaeyG7PJOyZdHsmYczj9ZhFBxXyV-qnyG1rSoT5dg1VfSh7rSENR6wloT3BsVw754lVqc0S5Wtfh5qPyAPkVYnKCKansz6nAhaJsF5ynHLwaAORwOu2BpSgRPSwe8XtsldijQwwlRQcyhjec2_djSMxMK801RJpogDhxCJ4xPVOONZLCnmE5iEaET4Qm8Gahz3l_KODOEe4WvC9xYg8WUnP0bz-_FFv_hv5XbI5ezaRey-nr26Rc4GTP6x1skU22nppbpOz-lM7b-o7Tqn8BLt_emk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cost-effectiveness+of+prehabilitation+of+elderly+frail+or+pre-frail+patients+prior+to+elective+surgery+%28PRAEP-GO%29+versus+usual+care+-+Protocol+for+a+health+economic+evaluation+alongside+a+randomized+controlled+trial&rft.jtitle=BMC+geriatrics&rft.au=Eckhardt%2C+Helene&rft.au=Quentin%2C+Wilm&rft.au=Silzle%2C+Julia&rft.au=Busse%2C+Reinhard&rft.date=2024-03-06&rft.issn=1471-2318&rft.eissn=1471-2318&rft.volume=24&rft.issue=1&rft.spage=231&rft_id=info:doi/10.1186%2Fs12877-024-04833-5&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2318&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2318&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2318&client=summon |